The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Clinical Trials, Phase II
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II 5 coordinate concepts∟ ∟ ∟ ∟ ∟ |
Broader terms: | ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ Clinical Trials, Phase II ∟ ∟ ∟ ∟ ∟ ∟ ∟ Clinical Trials, Phase II |
Annotation: | trial lasts about 2 years; for U.S. & foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II, for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles & books about phase II clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE II; DF: CLIN TRIALS PHASE II
X |
History note: | |
historyNote*: | 93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92
X |
onlineNote*: | use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE II 1980-92 & EVALUATION STUDIES, DRUG, FDA PHASE II 1982-92
X |
publicMeSHNote*: | 93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92
X |
Scope note: | Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
X |
activeMeSHYear*: | |
dateCreated*: | 1992-05-13X |
dateEstablished*: | 1993-01-01X |
dateRevised*: | 2001-07-25X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | agsX |
recordOriginator*: | TPWX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Kliiniset kokeet, vaihe II (fi) XKliininen koe, vaihe II (fi, replaced) Vaiheen II kliininen koe (fi, replaced) Vaiheen II kliiniset kokeet (fi, replaced) Kliniska prövningar, fas II (sv) Phase II Clinical Trials (en, replaced) Phase 2 Clinical Trials (en, replaced) Drug Evaluation, FDA Phase 2 (en, replaced) Evaluation Studies, FDA Phase 2 (en, replaced) Clinical Trials, Phase 2 (en, replaced) |
Share: |
Loading results...